Global Smart Pills Market Size, Growth Drivers, Trends, and Forecast 2026-2035 | AI-Enabled Diagnostics and Remote Monitoring Drive 11.8% CAGR to USD 3.9 Billion

Global Smart Pills Market Size, Growth Drivers, Trends, and Forecast 2026-2035 | AI-Enabled Diagnostics and Remote Monitoring Drive 11.8% CAGR to USD 3.9 Billion Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- "Smart Pills Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering.

The Global Smart Pills Market was valued at USD 1.3 billion in 2025 and is projected to reach USD 3.9 billion by 2035, expanding at a CAGR of 11.8%. Market growth is supported by the rising prevalence of gastrointestinal disorders, increasing demand for minimally invasive diagnostic procedures, and broader adoption of digital healthcare technologies.

Healthcare providers are increasingly implementing sensor-based medical solutions to improve diagnostic precision, patient monitoring, treatment adherence, and clinical decision-making. Advances in artificial intelligence, data analytics, microelectronics, wireless connectivity, and digital health platforms are enhancing the performance and clinical value of ingestible medical devices. Artificial intelligence enables healthcare professionals to process large volumes of patient data, identify relevant patterns, and develop more accurate treatment strategies.

Integration with Internet of Things technologies is also strengthening remote patient monitoring capabilities. Physicians can access physiological data without requiring frequent hospital visits, supporting more efficient disease management and reducing pressure on healthcare infrastructure. Continued innovation in sensor engineering, imaging, biocompatible materials, and wireless communication is expected to expand the use of smart pills across diagnostic, monitoring, and therapeutic applications.

The product segment generated USD 802.8 million in 2025. Smart capsules incorporating miniature sensors, microprocessors, and wireless communication technologies can transmit real time information related to gastrointestinal health, disease progression, and treatment adherence. These technologies also support precise drug delivery and continuous physiological monitoring. Their integration with wearable devices and connected digital health platforms is increasing their role in coordinated care while encouraging adoption across hospitals, diagnostic centers, and other clinical settings.

The stomach segment accounted for 44% of the Global Smart Pills Market in 2025. Its leading position reflects the growing use of ingestible technologies for evaluating gastric disorders and monitoring digestive health. Improvements in sensor accuracy, internal imaging, and wireless data transmission are enabling more precise assessment of stomach related conditions. Demand is also increasing as healthcare providers prioritize early detection and diagnostic approaches that minimize discomfort and procedural complications.

North America Smart Pills Market reached USD 503.5 million in 2025 and is forecast to grow at a CAGR of 11.5% from 2026-2035. The region benefits from advanced healthcare infrastructure, strong adoption of innovative medical technologies, and an established digital health ecosystem. The rising prevalence of gastrointestinal conditions and chronic diseases, combined with an aging population, is increasing demand for continuous monitoring and early diagnostic solutions.

North America is also supported by the presence of prominent pharmaceutical and medical device companies, ongoing research investments, healthcare innovation programs, and supportive government initiatives. These factors are accelerating product development, regulatory progress, and clinical implementation throughout the region.

Major companies operating in the Global Smart Pills Market include Medtronic, Olympus Corporation, Otsuka Holdings, CapsoVision, ANX Robotica, Bodycap, Intromedic, Check-Cap, etectRx, and RF Co. Market participants are investing in research and development to improve sensor technologies, wireless communication systems, data analytics platforms, and connected healthcare capabilities.

Competitive strategies include partnerships with healthcare providers, research institutions, and digital health companies to accelerate clinical validation and product commercialization. Companies are also pursuing regulatory approvals, strengthening global distribution networks, and entering new geographic markets. The integration of artificial intelligence and remote monitoring capabilities remains a central focus as manufacturers seek to deliver more actionable diagnostic insights and improve patient outcomes.

Comprehensive Market Analysis and Forecast

Key Attributes:

Key Topics Covered:

Chapter 1 Methodology and Scope

1.1 Market scope and definition

1.2 Research approach

1.3 Quality commitments

1.3.1 AI policy and data integrity commitment

1.3.1.1 Source consistency protocol

1.4 Research trail and confidence scoring

1.4.1 Research trail components

1.4.2 Scoring components

1.5 Data collection

1.5.1 Partial list of primary sources

1.6 Data mining sources

1.6.1 Paid sources

1.6.1.1 Sources, by region

1.7 Base estimates and calculations

1.7.1 Revenue share analysis

1.7.2 Base year calculation

1.8 Forecast model

1.9 Research transparency addendum

1.9.1 Source attribution framework

1.9.2 Quality assurance metrics

1.9.3 Our commitment to trust

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

2.1.1 Business trends

2.1.2 Regional trends

2.1.3 Component trends

2.1.4 Target area trends

2.1.5 Application trends

2.1.6 End use trends

2.2 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis

3.2 Industry impact forces

3.2.1 Growth drivers

3.2.1.1 Increasing prevalence of gastrointestinal disorders

3.2.1.2 Continuous improvements in smart pill technology

3.2.1.3 Growing demand for non-invasive diagnostic tools

3.2.2 Industry pitfalls and challenges

3.2.2.1 Stringent regulatory requirements

3.2.2.2 High cost of devices

3.2.3 Market opportunities

3.2.3.1 Integration with digital health ecosystems

3.2.3.2 Emerging market penetration

3.3 Growth potential analysis

3.4 Regulatory landscape (Driven by primary research)

3.4.1 North America

3.4.2 Europe

3.4.3 Asia-Pacific

3.5 Technology and innovation landscape

3.5.1 Current technologies

3.5.2 Emerging technologies

3.6 Pricing analysis (Driven by primary research)

3.7 Investment and funding landscape

3.8 Impact of AI and generative AI on the market

3.9 Porter's analysis

3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

4.1 Introduction

4.2 Company market share analysis

4.3 Company matrix analysis

4.4 Competitive analysis of major market players

4.5 Competitive positioning matrix

4.6 Key developments

4.6.1 Merger and acquisition

4.6.2 Partnership and collaboration

4.6.3 New product launches

4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, by Component, 2022-2035 ($ Mn)

5.1 Key trends

5.2 Product

5.2.1 Capsule

5.2.2 Other products

5.3 Patient monitoring software

Chapter 6 Market Estimates and Forecast, by Target Area, 2022-2035 ($ Mn)

6.1 Key trends

6.2 Stomach

6.3 Small intestine

6.4 Large intestine

6.5 Esophagus

Chapter 7 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)

7.1 Key trends

7.2 Capsule endoscopy

7.3 Targeted drug delivery

7.4 Vital sign monitoring

Chapter 8 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)

8.1 Key trends

8.2 Hospitals

8.3 Diagnostic centers

8.4 Other end users

Chapter 9 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)

9.1 Key trends

9.2 North America

9.2.1 U.S.

9.2.2 Canada

9.3 Europe

9.3.1 Germany

9.3.2 UK

9.3.3 France

9.3.4 Spain

9.3.5 Italy

9.3.6 Netherlands

9.4 Asia-Pacific

9.4.1 China

9.4.2 Japan

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.5 Latin America

9.5.1 Brazil

9.5.2 Mexico

9.5.3 Argentina

9.6 Middle East and Africa

9.6.1 South Africa

9.6.2 Saudi Arabia

9.6.3 UAE

Chapter 10 Company Profiles

10.1 ANX Robotica

10.2 Bodycap

10.3 CapsoVision

10.4 Check-Cap

10.5 etectRx

10.6 Intromedic

10.7 Medtronic

10.8 Otsuka Holdings

10.9 Olympus Corporation

10.10 RF Co.

For more information about this report visit https://www.researchandmarkets.com/r/9xdtgs

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.